Supplementary Data
Phenotypic features and analysis of genes supporting probiotic action unravel underlying perspectives of Bacillus velezensis VTX9 as a potential feed additive for swine
Ngoc Tung Quach1,2†, Thi Hanh Nguyen Vu1,2†, Ngoc Anh Nguyen1, Van The Nguyen1, Thi Lien Bui1, Son Chu Ky3, Tung Lam Le1, Ha Hoang1, Cao Cuong Ngo4, Thanh Thi Minh Le1, Trung Nam Nguyen1,2, Hoang Ha Chu1,2, Quyet Tien Phi1,2
1 Institute of Biotechnology, Vietnam Academy of Science and Technology, Hanoi 10000, Vietnam
2 Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi 10000, Vietnam
3 School of Biotechnology and Food Technology, Hanoi University of Science and Technology, Hanoi 100000, Vietnam
4 Vietnam-Russia Tropical Centre, Hanoi 100000, Vietnam
Correspondence:
Quyet Tien Phi, Associate Professor of Microbiology
Institute of Biotechnology, Vietnam Academy of Science and Technology, Hanoi, Vietnam Postal Code: 10000
Phone No: +84-4-37917973 Fax No: +84-4-38363144 E-mail: tienpq@ibt.ac.vn
Contents:
Table S1
Table S2
Fig. S1
Supplementary Table and Figures
Table S1. Phenotypic characteristics and antibiotic sensitivity of Bacillus sp. VTX9 and the type strain B. velezensis CR-502T.
Characteristic Bacillus sp. VTX9 B. velezensis CR-502T
Morphological characteristics
Shape Rods Rods
Size 0.6–0.9×1.5–2.1μm 0.5 ×1.5-3.5 μm
Motility + +
Gram staining + +
Spore formation + +
Physiological properties
Temperature range for growth 25–45 oC 15–45 oC
Optimum temperature 37 oC ND
pH range for growth 2–9 5–10
Optimum pH 6 ND
NaCl range for growth 1–8% 1–12%
Optimum NaCl 4% ND
Biochemical properties
Catalase + +
Oxidase + +
Amylase + +
Protease + +
Cellulase + +
Carbon utilization
Mannitol - +
Glucose + +
Lactose + +
D-Fructose + +
Inositol + +
Melibiose - -
D-Raffinose + +
Amygdalin + +
D-Sorbitol + +
Methyl-α-D-glycoside + +
D-Turanose - -
Antibiotic sensitivity
Amikasin (30 µg) S ND
Nalidixic acid (30 µg) S S
Kanamycin (30 µg) S S
Neomicin (30 µg) S ND
Chloramphenicol (30 µg) S S
Gentamicin (10 µg) S ND
Ciprofloxacin (5 µg) S ND
Meropenem (10 µg) S ND
Ceftazidime (30 µg) S R
Fosfomycin (200 µg) S ND
Tetracycline (30 UI) S ND
Levofloxacin (5 µg) S ND
* (+), positive result; (-), negative result; ND, not determined; S, sensitive; R, resistant.
Table S2. Genomic features predicted in the chromosome and plasmids of B. velezensis VTX9
Features Chromosome
Plasmid
pVTX9-1 pVTX9-2 pVTX9-3 pVTX9-4 pVTX9-5
Genome size (bp) 3,985,800 20,007 8,565 18,221 12,395 7,261
G + C content (%) 46.1 37.6 39.9 35.3 38.1 42.2
Genes (total) 3,964 28 12 31 27 13
CDSs (coding) 3,736 28 12 31 27 13
rRNAs 27 0 0 0 0 0
tRNAs 86 0 0 0 0 0
ncRNAs 5 0 0 0 0 0
Pseudogenes 110 0 0 0 0 0
CRISPRS 0 0 0 0 0 0
GenBank accession number CP074685 CP074686 CP074687 CP074688 CP074689 CP074690
Fig. S1. Scanning electron microscopic images showing the cell morphology (a) and spore (b) of Bacillus sp. VTX9.
Bacillus sp. VTX9 was grown as an overnight culture in the EPS medium at 37 °C. Scale bar is shown in each figure.